Document:

Exhibit
10.12

 

THIS
AMENDED AND RESTATED PROMISSORY NOTE (“NOTE”) HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED
(THE “SECURITIES ACT”). THIS NOTE HAS BEEN ACQUIRED FOR INVESTMENT ONLY AND MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED
IN THE ABSENCE OF REGISTRATION OF THE RESALE THEREOF UNDER THE SECURITIES ACT OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY IN FORM,
SCOPE AND SUBSTANCE TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED.

 

AMENDED
AND RESTATED PROMISSORY NOTE

 

	Principal Amount: $500,000	 Dated as of October 21, 2022 

 

WHEREAS,
on August 20, 2021, the Maker (as defined herein) issued that certain Promissory Note (the “Original Promissory
Note”), amended as of December 15, 2021 (the “December 15, 2021 Amended and Restated Promissory Note”)
and as of June 27, 2022 (the “June 27, 2022 Amended and Restated Promissory Note”, to the Payee (as defined
herein) or its registered assigns or successors in interest; and

 

WHEREAS,
the Maker and Payee desire to amend and restate in their entirety the Original Promissory Note, the December 15, 2021 Amended and Restated
Promissory Note, and June 27, 2022 Amended and Restated Promissory Note on the terms and conditions provided in this note (the “Amended
and Restated Promissory Note”).

 

NOW
THEREFORE, in consideration of the mutual covenants contained herein and other good and valuable consideration, the existence and sufficiency
of which is expressly recognized by each of the parties hereto, the parties agree as follows:

 

TMT
Acquisition Corp., a Cayman Islands exempted company with limited liability (the “Maker”), promises to pay to the
order of 2TM Holding LP, a Delaware limited partnership, or its registered assigns or successors in interest (the “Payee”),
or order, the principal sum of Five Hundred Thousand Dollars ($500,000) or such lesser amount as shall have been advanced by Payee to
Maker and shall remain unpaid under this Note on the Maturity Date (as defined below) in lawful money of the United States of America,
on the terms and conditions described below. All payments on this Note shall be made by check or wire transfer of immediately available
funds or as otherwise determined by the Maker to such account as the Payee may from time to time designate by written notice in accordance
with the provisions of this Note.

 

1.
Principal. The entire unpaid principal balance of Note shall be payable on the earlier of: (i) March 31, 2023, or (ii) the date
on which Maker consummates an initial public offering of its securities (such earlier date, the “Maturity Date”).
The principal balance may be prepaid at any time. Under no circumstances shall any individual, including but not limited to any
officer, director, employee or shareholder of the Maker, be obligated personally for any obligations or liabilities of the Maker
hereunder.

 

2.
Drawdown Requests. Maker and Payee agree that Maker may request, from time to time, up to Five Hundred Thousand Dollars
($500,000) in draw downs under this Note to be used for costs and expenses related to Maker’s formation and the proposed
initial public offering of its securities (the “IPO”). Principal of this Note may be drawn down from time to time
prior to the Maturity Date upon written request from Maker to Payee (each, a “Drawdown Request”). Each Drawdown
Request must state the amount to be drawn down, and must not be an amount less than Ten Thousand Dollars ($10,000). Payee shall fund
each Drawdown Request no later than three (3) business days after receipt of a Drawdown Request; provided, however, that the maximum
amount of drawdowns outstanding under this Note at any time may not exceed Five Hundred Thousand Dollars ($500,000). No fees,
payments or other amounts shall be due to Payee in connection with, or as a result of, any Drawdown Request by Maker.

 

    	 

     

    

 

 3. Interest. No interest shall accrue on the unpaid principal balance of this Note.

 

4.
Application of Payments. All payments shall be applied first to payment in full of any costs incurred in the collection of any
sum due under this Note, including (without limitation) reasonable attorney’s fees, then to the payment in full of any late
charges and finally to the reduction of the unpaid principal balance of this Note.

 

 5. Events of Default. The following shall constitute an event of default (“Event of Default”):

 

(a) Failure
to Make Required Payments. Failure by Maker to pay the principal amount due pursuant to this Note within five (5) business days
of the date specified above.

 

(b) Voluntary Bankruptcy, Etc. The commencement by Maker of a voluntary case under any applicable bankruptcy, insolvency,
reorganization, rehabilitation or other similar law, or the consent by it to the appointment of or taking possession by a receiver,
liquidator, assignee, trustee, custodian, sequestrator (or other similar official) of Maker or for any substantial part of its
property, or the making by it of any assignment for the benefit of creditors, or the failure of Maker generally to pay its debts as
such debts become due, or the taking of corporate action by Maker in furtherance of any of the foregoing.

 

(c) Involuntary Bankruptcy, Etc. The entry of a decree or order for relief by a court having jurisdiction in the premises in respect
of Maker in an involuntary case under any applicable bankruptcy, insolvency or other similar law, or appointing a receiver, liquidator,
assignee, custodian, trustee, sequestrator (or similar official) of Maker or for any substantial part of its property, or ordering the
winding-up or liquidation of its affairs, and the continuance of any such decree or order unstayed and in effect for a period of 60 consecutive
days.

  

6.
Remedies.

 

(a) Upon the occurrence of an Event of Default specified in Section 5(a) hereof, Payee may, by written notice to Maker, declare this Note
to be due immediately and payable, whereupon the unpaid principal amount of this Note, and all other amounts payable thereunder, shall
become immediately due and payable without presentment, demand, protest or other notice of any kind, all of which are hereby expressly
waived, anything contained herein or in the documents evidencing the same to the contrary notwithstanding.

 

(b) Upon the occurrence of an Event of Default specified in Sections 5(b) or 5(c), the unpaid principal balance of this Note, and all other
sums payable with regard to this Note, shall automatically and immediately become due and payable, in all cases without any action on
the part of Payee.

 

7.
Waivers. Maker and all endorsers and guarantors of, and sureties for, this Note waive presentment for payment, demand, notice of
dishonor, protest, and notice of protest with regard to the Note, all errors, defects and imperfections in any proceedings
instituted by Payee under the terms of this Note, and all benefits that might accrue to Maker by virtue of any present or future
laws exempting any property, real or personal, or any part of the proceeds arising from any sale of any such property, from
attachment, levy or sale under execution, or providing for any stay of execution, exemption from civil process, or extension of time
for payment; and Maker agrees that any real estate that may be levied upon pursuant to a judgment obtained by virtue hereof, on any
writ of execution issued hereon, may be sold upon any such writ in whole or in part in any order desired by Payee.

 

8.
Unconditional Liability. Maker hereby waives all notices in connection with the delivery, acceptance, performance, default, or
enforcement of the payment of this Note, and agrees that its liability shall be unconditional, without regard to the liability of
any other party, and shall not be affected in any manner by any indulgence, extension of time, renewal, waiver or modification
granted or consented to by Payee, and consents to any and all extensions of time, renewals, waivers, or modifications that may be
granted by Payee with respect to the payment or other provisions of this Note, and agrees that additional makers, endorsers,
guarantors, or sureties may become parties hereto without notice to Maker or affecting Maker’s liability hereunder.

 

    	 

     

    

 

9.
Notices. All notices, statements or other documents which are required or contemplated by this Agreement shall be: (i) in
writing and delivered personally or sent by first class registered or certified mail, overnight courier service or facsimile or
electronic transmission to the address designated in writing, (ii) by facsimile to the number most recently provided to such party
or such other address or fax number as may be designated in writing by such party and (iii) by electronic mail, to the electronic
mail address most recently provided to such party or such other electronic mail address as may be designated in writing by such
party. Any notice or other communication so transmitted shall be deemed to have been given on the day of delivery, if delivered
personally, on the business day following receipt of written confirmation, if sent by facsimile or electronic transmission, one (1)
business day after delivery to an overnight courier service or five (5) days after mailing if sent by mail.

 

10. Construction. THIS NOTE SHALL BE CONSTRUED AND ENFORCED IN ACCORDANCE WITH THE LAWS OF STATE OF NEW YORK, WITHOUT REGARD TO CONFLICT
OF LAW PROVISIONS THEREOF.

 

11. Severability. Any provision contained in this Note which is prohibited or unenforceable in any jurisdiction shall, as to such jurisdiction,
be ineffective to the extent of such prohibition or unenforceability without invalidating the remaining provisions hereof, and any such
prohibition or unenforceability in any jurisdiction shall not invalidate or render unenforceable such provision in any other jurisdiction.

 

12.
Trust Waiver. Notwithstanding anything herein to the contrary, the Payee hereby waives any and all right, title, interest or
claim of any kind (“Claim”) in or to any distribution of or from the trust account to be established in which the
proceeds of the IPO conducted by the Maker (including the deferred underwriters discounts and commissions) and the proceeds of the
sale of the units issued in a private placement to occur prior to the consummation of the IPO are to be deposited, as described in
greater detail in the registration statement and prospectus to be filed with the Securities and Exchange Commission in connection
with the IPO, and hereby agrees not to seek recourse, reimbursement, payment or satisfaction for any Claim against the trust account
for any reason whatsoever.

 

13.
Amendment; Waiver. Any amendment hereto or waiver of any provision hereof may be made with, and only with, the written consent
of the Maker and the Payee.

 

14.
Assignment. No assignment or transfer of this Note or any rights or obligations hereunder may be made by any party hereto (by
operation of law or otherwise) without the prior written consent of the other party hereto and any attempted assignment without the
required consent shall be void.

 

    	 

     

    

 

IN
WITNESS WHEREOF, Maker, intending to be legally bound hereby, has caused this Note to be duly executed by the undersigned as of the
day and year first above written.

 

	 	TMT
    Acquisition Corp.
	 	 
	 	By:
	 
	 	Name:	Dajiang
    Guo
	 	Title:	Chief
    Executive Officer

 

[Signature
Page to Promissory Note]Document

Exhibit 10.1

Amendment to Employment Agreement
This Amendment to Employment Agreement (this “Amendment”) is made on September 26, 2022 (the “Amendment Effective Date”) by and between SciPlay Parent Company, LLC, a Nevada limited liability company, (the “Company”) and Josh Wilson (“Executive”).
WHEREAS, the Company and Executive entered into an Employment Agreement dated as of May 7, 2019 (the “Agreement”);
NOW THEREFORE, in consideration of the premises and the mutual benefits to be derived herefrom and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties agree as follows: 
1.         Extension of Term.  The parties agree that the “Term,” as defined in Section 1 of the Agreement, is extended until the third anniversary of the Amendment Effective Date.
2.         Increase in Base Salary.  The Agreement is hereby amended by adding the following sentence to the end of Section 3(a): “Effective as of May 8, 2022, Executive’s base salary is increased to six hundred thousand U.S. dollars ($600,000) per annum.”
3.         Continued Eligibility for Short-Term Incentive Compensation Program.  Executive will continue to have the opportunity annually to earn up to 100% of Executive’s base salary as cash incentive compensation in connection with Section 3(b) of the Agreement.
4.         Continued Eligibility for SEIP.  Executive will continue to be eligible to participate in the SEIP in accordance with its terms as set forth in Section 3(c) of the Agreement, and Executive’s target percentage for the SEIP will be 200% of Executive’s base salary with a “maximum opportunity” of up to 400% of Executive’s base salary.
5.         Increase in Executive’s Long-Term Incentive Compensation Program Target Percentage.  Effective as of May 8, 2022, Section 3(d) of the Agreement is hereby amended by increasing Executive’s target percentage for long-term incentive grants from 125% to 200%.
6.         Eligibility for Continued Medical Coverage in Section 4(e)(iv).  Section 4(e)(iv) is deleted and replaced with the following:
(iv)       if Executive timely elects to continue medical coverage under the Company’s group health plan in accordance with COBRA, the full monthly premiums for such coverage on a monthly basis until the earlier of: (A) a period of eighteen (18) months has elapsed; or (B) Executive is eligible for medical coverage under a plan provided by a new employer. In addition, if the eighteen (18) month period set forth in the foregoing sub-section (A) expires before Executive is eligible for medical coverage under a plan provided by a new employer, then the Company shall pay the full monthly premiums for Executive’s medical coverage under a health plan obtained by Executive that is comparable to the Company’s group health plan, until the earlier of a period of six (6) additional months has elapsed (for the avoidance of doubt, until the end of the 24-month period following the date of such termination) or Executive is eligible for medical coverage under a plan provided by a new employer; and
7.         Change to Severance Benefits in Section 4(f), “Expiration of Term of Agreement.”  Section 4(f) is deleted in its entirety and replaced with the following:
1

(f)        Expiration of Term of Agreement.  In the event Executive’s employment is terminated by the Company at the end of the Term, Executive shall receive:
1. the Standard Termination Payments; 
2.an amount equal to the sum of (A) Executive’s annual base salary then in effect multiplied by two (2) and (B) the Severance Bonus Amount, such amount under this clause (ii) payable in equal installments in accordance with the Company’s normal payroll practices over a period of twenty-four (24) months after such termination, and otherwise in accordance with Section 4(g); 
(iii)       no later than March 15 following the end of the year in which such termination occurs, in lieu of any Cash Incentive Compensation for the year in which such termination occurs, payment of an amount equal to (A) the Cash Incentive Compensation which would have been payable to Executive had Executive remained in employment with the Company during the entire year in which such termination occurred, multiplied by (B) a fraction the numerator of which is the number of days Executive was employed by the Company in the year in which such termination occurs and the denominator of which is the total number of days in the year in which such termination occurs;
(iv)       if Executive timely elects to continue medical coverage under the Company’s group health plan in accordance with COBRA, the full monthly premiums for such coverage on a monthly basis until the earlier of: (A) a period of eighteen (18) months has elapsed; or (B) Executive is eligible for medical coverage under a plan provided by a new employer. In addition, if the eighteen (18) month period set forth in the foregoing sub-section (A) expires before Executive is eligible for medical coverage under a plan provided by a new employer, then the Company shall pay the full monthly premiums for Executive’s medical coverage under a health plan obtained by Executive that is comparable to the Company’s group health plan, until the earlier of a period of six (6) additional months has elapsed (for the avoidance of doubt, until the end of the 24-month period following the date of such termination) or Executive is eligible for medical coverage under a plan provided by a new employer; and
(v)        the Pro-Rata SEIP Payment.
8.         Mitigation.  Section 4(h), “Mitigation,” is deleted and replaced with the following:
(h)        Mitigation.  In the event the Executive’s employment is terminated in accordance with Section 4(e) or (f) and Executive is employed by or otherwise engaged to provide services to another person or entity at any time prior to the end of any period of payments to or on behalf of Executive contemplated by this Section 4, (i) Executive shall immediately advise the Company of such employment or engagement and any health insurance benefits to which he is entitled in connection therewith, and (ii) the Company’s obligation to make continued health insurance payments to or on behalf of Executive shall be reduced by any health insurance coverage obtained by Executive during the applicable period through such other employment or engagement (without regard to when such coverage is paid).
9.         Extension Equity Awards.  In connection with entering into this Amendment and extending the Agreement, the Company will make the following equity awards to Executive:
a.          The Company will grant to Executive an equity award consisting of $1,200,000 worth of time-vesting RSUs (the “Time-Vested Amendment Equity Award”).    One-third of the Time-Vested Amendment Equity Award shall vest on each of the first three (3) anniversaries of the Amendment Effective Date.  
2

b.         The Company will grant to Executive an equity award consisting of $4,800,000 worth of performance-conditioned RSUs (the “Performance-Conditioned Amendment Equity Award”).  The Performance-Conditioned Amendment Equity Award shall be eligible to cliff vest on the third anniversary date of the Amendment Effective Date subject to the achievement of the AEBITDA and revenue targets in the Company’s long range plan as of the date of the Amendment.  
c.         The number of RSUs granted in connection with the Time-Vested Amendment Equity Award and Performance-Conditioned Amendment Equity Award shall be determined based on the average high-low price of SCPL stock on the last trading day prior to the grant date.  The grants will be made within ten (10) days after the Amendment Effective Date if the Company is not in a blackout period on the Amendment Effective Date.  If the Company is in a blackout period on the Amendment Effective Date, then the grants will be made within three (3) trading days after the Company’s next trading window opens.  
d.         The Time-Vested Amendment Equity Award and Performance-Conditioned Amendment Equity Award shall be subject to the terms of the Company’s standard form of award agreement.
10.       Except as set forth in this Amendment, all terms and conditions of the Agreement shall remain unchanged and in full force and effect in accordance with their terms.  All references to the “Agreement” in the Agreement shall refer to the Agreement as amended by this Amendment. Any defined terms used in this Amendment and not defined herein shall have the meaning as set forth in the Agreement.
11.       This Amendment may be executed in counterparts, each of which shall for all purposes be deemed to be an original and all of which shall constitute the same instrument.  Delivery of an executed counterpart of a signature page of this Amendment by electronic transmission shall be effective as delivery of a manually executed counterpart of this Amendment.
IN WITNESS WHEREOF, each of the parties hereto has duly executed this Amendment as of September 26, 2022.

SciPlay Parent Company, LLC

By:   /s/ Daniel O’Quinn                              
Name:  Daniel O’Quinn
Title:  Interim Chief Financial Officer

/s/ Josh Wilson                                             
Josh Wilson
3

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00350-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00350-of-00352.parquet"}]]